SEC 13F Intelligence

Birchview Capital, LP / SILKUSD

Birchview Capital, LP’s Silk Road Medical Inc Position

Does Birchview Capital, LP own Silk Road Medical Inc (SILKUSD)? Not currently — the last reported position was 158.1K shares worth $4M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q2 2024
Shares
158.1K
% of Portfolio
+3.96%
Quarters Held
11
position exited

Position History SILKUSD

Reported value by quarter
Q4 ’21: $341,000Q4 ’21Q1 ’22: $413,000Q2 ’22: $364,000Q2 ’22Q3 ’22: $450,000Q4 ’22: $529Q4 ’22Q1 ’23: $391Q2 ’23: $649,800Q2 ’23Q3 ’23: $618,997Q4 ’23: $2MQ4 ’23Q1 ’24: $3MQ2 ’24: $4MQ2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2024158.1K$4M+3.96%
Q1 2024158.1K$3M+2.36%
Q4 2023158.1K$2M+1.52%
Q3 202341.3K$618,997+0.53%
Q2 202320.0K$649,800+0.49%
Q1 202310.0K$391+0.31%
Q4 202210.0K$529+0.37%
Q3 202210.0K$450,000+0.32%
Q2 202210.0K$364,000+0.26%
Q1 202210.0K$413,000+0.30%
Q4 20218.0K$341,000+0.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of SILKUSD.